Pricing & Availability

How much will pet GLP-1 cost, and when can you actually get it?

Cats: Treatments are being studied in cats. No GLP-1 is approved for pet weight loss, and official pricing has not been announced. See the cat studies.
Dogs: The named dog GLP-1 candidates are preclinical. There is no confirmed launch date or official price. See the dog candidates.

There is no approved pet weight-loss GLP-1 on sale and no official price to quote. The figures below are reported targets or estimates, not a treatment bill or a confirmed annual budget. A trial result does not establish approval or a launch date. Talk with your veterinarian about currently available weight-management options; a human GLP-1 prescription is not a route to a pet product.

Nothing here is a confirmed price.Neither Okava nor Akston has announced a confirmed retail price. The OKV-119 figure is a reported development target; it does not include a confirmed price for implant placement, exams or monitoring.

What pricing has been reported?

Drug	Format	Pricing evidence	Status
Okava OKV-119 (cats)	~6-month implant	About $100/month anticipated in a December 2025 founder interview; no confirmed retail or procedure price	Trial, readout estimated summer 2027
Akston AKS-562c (cats)	Weekly injection	No confirmed retail or per-dose price	Cornell trial, no public price
Canine GLP-1 (dogs)	AKS-724d / AKS-725d named in mouse testing	No basis for an estimate yet	Preclinical, no launch window

Pricing source: Inc.'s interview with Okava founder Michael Klotsman, December 17, 2025. This is a development target, not a current veterinary quote.

How it will be distributed

These are prescription veterinary medications. Expect them to be prescribed and dispensed the way other long-acting vet drugs are: through your veterinarian or a veterinary pharmacy, after an exam and a body-condition assessment. There is no over-the-counter path and no human-telehealth path for a pet GLP-1.

Prices for flea, tick or heartworm preventatives do not establish a price for an investigational GLP-1. The final veterinary bill could include the medicine, administration, exams and monitoring. None of those charges has been confirmed for a marketed pet GLP-1 product.

When you can actually get it

•Summer 2027, estimated: Okava MEOW-1 cat trial reads out. A readout could add efficacy evidence; it is not an approval.
•Cats: no confirmed commercial launch date. A positive trial readout is a development milestone; additional evidence, manufacturing review and a regulatory decision may still be needed.
•Dogs: no evidence-based launch window. Akston's named candidates are preclinical and no canine GLP-1 clinical trial has started.

The FDA explains the animal-drug application process; a study announcement is not a marketing authorization.

For the full milestone-by-milestone view, see the Okava and Akston pipeline tracker. To be told the day pricing and availability are announced, get on the launch alert list. Dog owners tracking the canine side separately can start at our hub for GLP-1 drugs for dogs, which tracks every canine programme that has actually been filed.

Pricing FAQ

How much will pet GLP-1 cost?+

Neither Okava nor Akston has announced a confirmed retail price. Inc.'s December 17, 2025 interview with Okava founder Michael Klotsman reported an anticipated price of about $100 per month for OKV-119. That development target is not an available offer. No substantiated retail price is available for Akston's AKS-562c.

What is the total yearly cost for an owner?+

There is no confirmed annual owner cost. A drug-price target does not establish the eventual charge for the medicine, implant placement, veterinary exams or monitoring. Ask for an itemized veterinary quote if a product is approved and offered; no current pet GLP-1 treatment bill can be calculated from the trial announcements.

Will I be able to buy it over the counter?+

No. These are prescription veterinary drugs. They will be prescribed and dispensed through your veterinarian or a veterinary pharmacy, not sold over the counter or through human telehealth. A vet exam and a body-condition assessment will almost certainly be required first.

When can I actually get it?+

Cats are clinically further along, but no pet GLP-1 has an approved launch date. For dogs, Akston's named candidates are still preclinical, so there is no evidence-based commercial window. Availability depends on successful studies, manufacturing review and FDA-CVM review.

Note on pricing: No pet weight-loss GLP-1 medication is approved or for sale as of the source checks. A reported development price target is not a confirmed retail price or a total veterinary bill. This page is informational and is not veterinary advice.